Amtrust Financial Services, Inc. Catalyst Biosciences, Inc. Transaction History

Amtrust Financial Services, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.55 - $7.29 $105,892 - $169,660	-23,273 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$4.22 - $6.04 $112,787 - $161,431	-26,727 Reduced 53.45%	23,273 $100,000
Q2 2020 Aug 12, 2020	BUY	$3.76 - $8.01 $188,000 - $400,500	50,000 New	50,000 $294,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Amtrust Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Amtrust Financial Services, Inc. with notifications on news.